EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

21 hedge funds and large institutions have $41.8M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.23M
2
+$5.99M
3
+$4.5M
4
CH
CVI Holdings
Delaware
+$3.51M
5
SFM
Sphera Funds Management
Israel
+$3.01M

Top Sellers

1
-$1.82M
2
-$34.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$9.23M
2
$5.99M
3
$4.5M
4
$3.92M
5
$3.51M
6
$3.01M
7
$2M
8
$2M
9
$1.04M
10
$998K
11
$998K
12
$998K
13
$834K
14
$756K
15
$652K
16
$571K
17
$499K
18
$127K
19
$104K
20
$39K